234 related articles for article (PubMed ID: 27930590)
1. Low mortality but increasing incidence of Staphylococcus aureus endocarditis in people who inject drugs: Experience from a Swedish referral hospital.
Asgeirsson H; Thalme A; Weiland O
Medicine (Baltimore); 2016 Dec; 95(49):e5617. PubMed ID: 27930590
[TBL] [Abstract][Full Text] [Related]
2. Incidence and outcome of Staphylococcus aureus endocarditis--a 10-year single-centre northern European experience.
Asgeirsson H; Thalme A; Kristjansson M; Weiland O
Clin Microbiol Infect; 2015 Aug; 21(8):772-8. PubMed ID: 25934159
[TBL] [Abstract][Full Text] [Related]
3. Staphylococcus aureus bacteraemia and endocarditis - epidemiology and outcome: a review.
Asgeirsson H; Thalme A; Weiland O
Infect Dis (Lond); 2018 Mar; 50(3):175-192. PubMed ID: 29105519
[TBL] [Abstract][Full Text] [Related]
4. Endocarditis caused by Staphylococcus aureus: A reappraisal of the epidemiologic, clinical, and pathologic manifestations with analysis of factors determining outcome.
Fernández Guerrero ML; González López JJ; Goyenechea A; Fraile J; de Górgolas M
Medicine (Baltimore); 2009 Jan; 88(1):1-22. PubMed ID: 19352296
[TBL] [Abstract][Full Text] [Related]
5. Cardiac surgery for infective endocarditis in patients with intravenous drug use.
Østerdal OB; Salminen PR; Jordal S; Sjursen H; Wendelbo Ø; Haaverstad R
Interact Cardiovasc Thorac Surg; 2016 May; 22(5):633-40. PubMed ID: 26826713
[TBL] [Abstract][Full Text] [Related]
6. Prospective Cohort Study of Infective Endocarditis in People Who Inject Drugs.
Pericàs JM; Llopis J; Athan E; Hernández-Meneses M; Hannan MM; Murdoch DR; Kanafani Z; Freiberger T; Strahilevitz J; Fernández-Hidalgo N; Lamas C; Durante-Mangoni E; Tattevin P; Nacinovich F; Chu VH; Miró JM;
J Am Coll Cardiol; 2021 Feb; 77(5):544-555. PubMed ID: 33538252
[TBL] [Abstract][Full Text] [Related]
7. [Epidemiology of infective endocarditis in intravenous drug users].
Crociani P; Schivazappa L
G Ital Cardiol (Rome); 2022 Nov; 23(11):845-853. PubMed ID: 36300388
[TBL] [Abstract][Full Text] [Related]
8. Impact of a Plan of Care Protocol on Patient Outcomes in People Who Inject Drugs With Infective Endocarditis.
Cooksey GE; Epps JL; Moye RA; Patel N; Shorman MA; Veve MP
J Infect Dis; 2020 Sep; 222(Suppl 5):S506-S512. PubMed ID: 32877564
[TBL] [Abstract][Full Text] [Related]
9. The epidemiology of infective endocarditis with focus on non-device related right-sided infective endocarditis: A retrospective register-based study in the region of Southern Denmark.
Lassen H; Nielsen SL; Gill SUA; Johansen IS
Int J Infect Dis; 2020 Jun; 95():224-230. PubMed ID: 32289560
[TBL] [Abstract][Full Text] [Related]
10. The changing landscape of infective endocarditis in South Africa.
De Villiers MC; Viljoen CA; Manning K; Van der Westhuizen C; Seedat A; Rath M; Graham M; Ntsekhe M
S Afr Med J; 2019 Jul; 109(8):592-596. PubMed ID: 31456555
[TBL] [Abstract][Full Text] [Related]
11. Staphylococcus aureus endocarditis associated with injecting new psychoactive substances.
Joshi SS; Henderson N; Griffith DJ; Henriksen PA; Denvir MA; Macsween KF; Mackintosh CL; Inverarity D
J R Coll Physicians Edinb; 2018 Dec; 48(4):304-310. PubMed ID: 30488883
[TBL] [Abstract][Full Text] [Related]
12. Comparing right- and left sided injection-drug related infective endocarditis.
Clarelin A; Rasmussen M; Olaison L; Ragnarsson S
Sci Rep; 2021 Jan; 11(1):1177. PubMed ID: 33441950
[TBL] [Abstract][Full Text] [Related]
13. Staphylococcus aureus endocarditis in Danish intravenous drug users: high proportion of left-sided endocarditis.
Faber M; Frimodt-Møller N; Espersen F; Skinhøj P; Rosdahl V
Scand J Infect Dis; 1995; 27(5):483-7. PubMed ID: 8588139
[TBL] [Abstract][Full Text] [Related]
14. Risk of New Bloodstream Infections and Mortality Among People Who Inject Drugs With Infective Endocarditis.
Tan C; Shojaei E; Wiener J; Shah M; Koivu S; Silverman M
JAMA Netw Open; 2020 Aug; 3(8):e2012974. PubMed ID: 32785635
[TBL] [Abstract][Full Text] [Related]
15. [Native valve endocarditis caused by Staphylococcus aureus and streptococci. A comparative study].
Cartón JA; Maradona JA; Asensi Alvarez V
Rev Clin Esp; 1995 Nov; 195(11):744-51. PubMed ID: 8560029
[TBL] [Abstract][Full Text] [Related]
16. Community-Acquired Staphylococcus aureus Bacteremia Among People Who Inject Drugs: A National Cohort Study in England, 2017-2020.
McGuire E; Collin SM; Brown CS; Saito M
Clin Infect Dis; 2024 Jun; 78(6):1443-1450. PubMed ID: 38315893
[TBL] [Abstract][Full Text] [Related]
17. Multiple-valve infective endocarditis: clinical, microbiologic, echocardiographic, and prognostic profile.
López J; Revilla A; Vilacosta I; Sevilla T; García H; Gómez I; Pozo E; Sarriá C; San Román JA
Medicine (Baltimore); 2011 Jul; 90(4):231-236. PubMed ID: 21694644
[TBL] [Abstract][Full Text] [Related]
18. Comparison of prognoses of Staphylococcus aureus left-sided prosthetic endocarditis and prosthetic endocarditis caused by other pathogens.
Abdallah L; Habib G; Remadi JP; Salaun E; Casalta JP; Tribouilloy C
Arch Cardiovasc Dis; 2016 Oct; 109(10):542-549. PubMed ID: 27342809
[TBL] [Abstract][Full Text] [Related]
19. Infective endocarditis in Western Norway: a 20-year retrospective survey.
Jordal S; Kittang BR; Salminen PR; Eide GE; Kommedal Ø; Wendelbo Ø; Haaverstad R; Sjursen H
Infect Dis (Lond); 2018 Oct; 50(10):757-763. PubMed ID: 29916753
[TBL] [Abstract][Full Text] [Related]
20. Features of infective endocarditis in a contemporary cohort of persons who inject drugs: a matched comparison analysis of long-term prognostic factors.
Ramadan MS; Bertolino L; Boccia F; Hamieh M; Peluso AM; Gallo R; Patauner F; De Santo LS; Carozza A; Zampino R; Durante-Mangoni E;
Intern Emerg Med; 2024 Mar; 19(2):455-464. PubMed ID: 38129537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
